An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1869-6961
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
An Indirect Comparison of Basal Insulin Plus Once-Weekly Semaglutide and Fully Optimised Basal–Bolus Insulin in Type 2 Diabetes ; volume:14 ; number:1 ; day:25 ; month:11 ; year:2022 ; pages:123-137 ; date:1.2023
Diabetes therapy ; 14, Heft 1 (25.11.2022), 123-137, 1.2023
- Creator
-
Lingvay, Ildiko
Catarig, Andrei-Mircea
Lawson, Jack
Chubb, Barrie
Gorst-Rasmussen, Anders
Evans, Lyndon Marc
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13300-022-01344-7
- URN
-
urn:nbn:de:101:1-2023040321054850830826
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lingvay, Ildiko
- Catarig, Andrei-Mircea
- Lawson, Jack
- Chubb, Barrie
- Gorst-Rasmussen, Anders
- Evans, Lyndon Marc
- SpringerLink (Online service)
Other Objects (12)
Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes
Excess weight gain during insulin pump therapy is associated with higher basal insulin doses
Correction to: The basal to total insulin ratio in outpatients with diabetes on basal-bolus regimen
Addition of a single short-acting insulin bolus to basal insulin-supported oral therapy: a systematic review of data on the basal-plus regimen
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study
Diabetes Management and Healthcare Resource Use When Intensifying from Basal Insulin to Basal-Bolus: A Survey of Type 2 Diabetes Patients
Fasting plasma glucose level-based formula for estimating starting daily dose in basal-bolus insulin therapy
Basal-Bolus Insulin Regimen for Hospitalised Patients with COVID-19 and Diabetes Mellitus: A Practical Approach
Safety and Effectiveness of Insulin Aspart in Basal-Bolus Regimens Regardless of Age: A1chieve Study Results
Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens
Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes
A 32-Week Randomized Comparison of Stepwise Insulin Intensification of Biphasic Insulin Aspart (BIAsp 30) Versus Basal–Bolus Therapy in Insulin-Naïve Patients with Type 2 Diabetes